Tristel PLC - Positive Trading Update

Tristel plc
("Tristel" or the "Company")
Positive Trading Update
Results in line with market expectations
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a trading update for the year ended
FY 2026 Financial Highlights
· Revenues up 10% to
· Adjusted EBITDA margin remains comfortably above the 25% target
· 14% growth in adjusted profit before tax2 which is expected to be no less than
· Tristel continues to be debt free and cash generative which supports continued growth in overseas territories
· Cash balances on
1 Management understands consensus forecasts for FY 2026 to be revenues of
2 Adjusted for share-based payments, exceptional items and Research and Development tax credit
"We continue to meet our performance targets of delivering double-digit revenue growth each year, and maintaining adjusted EBITDA margins of at least 25%. We remain debt-free, cash-generative, and confident in our ability to continue to sustain this momentum in the years ahead.
"We are very excited to welcome our new CEO,
For further information please contact:
|
Tristel plc |
Via Walbrook PR |
||
|
|
|||
|
|
|
||
|
|
|
||
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
||
|
|
Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 |
||
|
|
|
||
|
Cavendish Capital Markets Ltd |
Tel: 020 7220 0500 |
||
|
|
|
||
|
|
|
||


About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre‑wetted plastic wipe.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries.
Performance targets
The Company targets delivering double-digit revenue growth annually, an adjusted EBITDA margin of at least 25% and a continuing progressive year-on-year growth in dividends, underpinned by robust cash generation.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).
Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.
Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.
This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.
This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.
FOR OUR FULL DISCLAIMER CLICK HERE